Journal of Translational Medicine | |
Obesity is associated with a decrease in expression but not with the hypermethylation of thermogenesis-related genes in adipose tissues | |
Monika Puzianowska-Kuznicka3  Andrzej Chmura2  Zbigniew Wierzbicki2  Zofia Agnieszka Wicik1  Maurycy Jonas2  Wojciech Lisik2  Marta Jonas1  Alina Kurylowicz1  | |
[1] Department of Human Epigenetics, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawinskiego Street, Warsaw, 02-106, Poland;Department of General and Transplantation Surgery, Medical University of Warsaw, 59 Nowogrodzka Street, Warsaw, 02-005, Poland;Department of Geriatrics and Gerontology, Medical Centre of Postgraduate Education, 99 Marymoncka Street, Warsaw, 01-813, Poland | |
关键词: Methylation; Uncoupling proteins; 5’-iodothyronine deiodinases; Thyroid hormone receptors; Adrenergic receptors; Obesity; | |
Others : 1137698 DOI : 10.1186/s12967-015-0395-2 |
|
received in 2014-09-22, accepted in 2015-01-14, 发布年份 2015 | |
【 摘 要 】
Background
Impaired thermogenesis can promote obesity. Therefore, the aim of this study was to investigate whether the expression of thermogenesis-related genes is altered in adipose tissues of obese individuals and whether excessive methylation of their promoters is involved in this phenomenon.
Methods
The expression of genes encoding β adrenergic receptors (ADRBs), thyroid hormone receptors (THRs), 5’-iodothyronine deiodinases (DIOs), and uncoupling proteins (UCPs) was measured by real-time PCR in visceral and in subcutaneous adipose tissues of 58 obese (BMI >40 kg/m2) and 50 slim (BMI 20-24.9 kg/m2) individuals. The methylation status of these genes was studied by the methylation-sensitive digestion/real-time PCR method.
Results
The expression of ADRB2, ADRB3, THRA, THRB, DIO2, UCP2 was significantly lower in the adipose tissues of obese patients than in tissues of normal-weight individuals (P < 0.00001). In the obese, the expression of ADRB2, ADRB3, DIO2 was lower in visceral adipose tissue than in subcutaneous adipose tissue (P = 0.008, P = 0.002, P = 0.001, respectively). However, the mean methylation of CpG islands of these genes was similar in tissues with their high and low expression, and there was no correlation between the level of expression and the level of methylation.
Conclusions
Decreased expression of thermogenesis-related genes in adipose tissues of obese patients might result in the reduced reactivity to both hormonal and adrenergic stimuli and therefore in a lower potential to activate thermogenesis.
【 授权许可】
2015 Kurylowicz et al.; licensee BioMed Central.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20150317140137269.pdf | 997KB | download | |
Figure 4. | 24KB | Image | download |
Figure 3. | 20KB | Image | download |
Figure 2. | 48KB | Image | download |
Figure 1. | 23KB | Image | download |
【 图 表 】
Figure 1.
Figure 2.
Figure 3.
Figure 4.
【 参考文献 】
- [1]Guyenet SJ, Schwartz MW: Clinical review: regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity. J Clin Endocrinol Metab 2012, 97:745-55.
- [2]Aronne LJ, Wadden T, Isoldi KK, Woodworth KA: When prevention fails: obesity treatment strategies. Am J Med 2009, 122(4 Suppl 1):S24-32.
- [3]Dawkins MJ, Scopes JW: Non-shivering thermogenesis and brown adipose tissue in the human new-born infant. Nature 1965, 206:201-2.
- [4]Chechi K, Nedergaard J, Richard D: Brown adipose tissue as an anti-obesity tissue in humans. Obes Rev 2014, 15:92-106.
- [5]Xue B, Rim JS, Hogan JC, Coulter AA, Koza RA, Kozak LP: Genetic variability affects the development of brown adipocytes in white fat but not in interscapular brown fat. J Lipid Res 2007, 48:41-51.
- [6]Bukowiecki L, Collet AJ, Follea N, Guay G, Jahjah L: Brown adipose tissue hyperplasia: a fundamental mechanism of adaptation to cold and hyperphagia. Am J Physiol 1982, 242:E353-9.
- [7]Collins S, Surwit RS: The β-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog Horm Res 2001, 56:309-28.
- [8]Hellström L, Wahrenberg H, Reynisdottir S, Arner P: Catecholamine-induced adipocyte lipolysis in human hyperthyroidism. J Clin Endocrinol Metab 1997, 82:159-66.
- [9]Rubio A, Raasmaja A, Silva JE: Thyroid hormone and norepinephrine signaling in brown adipose tissue. II: differential effects of thyroid hormone on β3-adrenergic receptors in brown and white adipose tissue. Endocrinology 1995, 136:3277-84.
- [10]de Jesus LA, Carvalho SD, Ribeiro MO, Schneider M, Kim SW, Harney JW, et al.: The type 2 iodothyroninedeiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest 2001, 108:1379-85.
- [11]Silva JE: Thermogenic mechanisms and their hormonal regulation. Physiol Rev 2006, 86:435-64.
- [12]Silva JE, Bianco SD: Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid 2008, 18:157-65.
- [13]Braitman LE, Adlin EV, Stanton JL Jr: Obesity and caloric intake: the National Health and Nutrition Examination Survey of 1971–1975 (HANES I). J Chronic Dis 1985, 38:727-32.
- [14]Marsili A, Aguayo-Mazzucato C, Chen T, Kumar A, Chung M, Lunsford EP, et al.: Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity. PLoS One 2011, 6:e20832.
- [15]Bachman ES, Dhillon H, Zhang CY, Cinti S, Bianco AC, Kobilka BK, et al.: βAR signaling required for diet-induced thermogenesis and obesity resistance. Science 2002, 297:843-5.
- [16]Pelletier P, Gauthier K, Sideleva O, Samarut J, Silva JE: Mice lacking the thyroid hormone receptor α gene spend more energy in thermogenesis, burn more fat, and are less sensitive to high-fat diet-induced obesity. Endocrinology 2008, 149:6471-86.
- [17]Ukropec J, Anunciado RP, Ravussin Y, Hulver MW, Kozak LP: UCP1-independent thermogenesis in white adipose tissue of cold-acclimated Ucp1-/- mice. J Biol Chem 2006, 281:31894-908.
- [18]Gong DW, Monemdjou S, Gavrilova O, Leon LR, Marcus-Samuels B, Chou CJ, et al.: Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem 2000, 275:16251-7.
- [19]Tseng YH, Cypess AM, Kahn CR: Cellular bioenergetics as a target for obesity therapy. Nat Rev Drug Discov 2010, 9:465-82.
- [20]Fujiki K, Kano F, Shiota K, Murata M: Expression of the peroxisome proliferator activated receptor gamma gene is regulated by DNA methylation in visceral tissue of mouse. BMC Biol 2009, 7:38. BioMed Central Full Text
- [21]Pogribny IP, Tryndyak VP, Bagnyukova TV, Melnyk S, Montgomery B, Ross SA, et al.: Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol 2009, 51:176-86.
- [22]Bouchard L, Rabasa-Lhoret R, Faraj M, Lavoie ME, Mill J, Pérusse L, et al.: Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue between low and high responders to caloric restriction. Am J Clin Nutr 2010, 91:309-20.
- [23]Jalba MS, Rhoads GG, Demissie K: Association of codon 16 and codon 27 β2-adrenergic receptor gene polymorphisms with obesity: a meta-analysis. Obesity 2008, 16:2096-106.
- [24]Mirrakhimov AE, Kerimkulova AS, Lunegova OS, Moldokeeva CB, Zalesskaya YV, Abilova SS, et al.: An association between TRP64ARG polymorphism of the β3 adrenoreceptor gene and some metabolic disturbances. Cardiovasc Diabetol 2011, 10:89. BioMed Central Full Text
- [25]Liu ZQ, Mo W, Huang Q, Zhou HH: Genetic polymorphisms of human β-adrenergic receptor genes and their association with obesity. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2007, 32:359-67.
- [26]Masuo K: Roles of β2- and β3-adrenoceptor polymorphisms in hypertension and metabolic syndrome. Int J Hypertens 2010, 2010:1-12.
- [27]Andersson D, Wahrenberg H, Löfgren P: β3-adrenoceptor function and long-term changes in body weight. Int J Obes 2009, 33:662-8.
- [28]Wijers SL, Schrauwen P, van Baak MA, Saris WH, van Marken Lichtenbelt WD: β-adrenergic receptor blockade does not inhibit cold-induced thermogenesis in humans: possible involvement of brown adipose tissue. J Clin Endocrinol Metab 2001, 96:E598-605.
- [29]Fiorito M, Torrente I, De Cosmo S, Guida V, Colosimo A, Prudente S, et al.: Interaction of DIO2 T92A and PPARγ2 P12A polymorphisms in the modulation of metabolic syndrome. Obesity 2007, 15:2889-95.
- [30]Fernández-Real JM, Corella D, Goumidi L, Mercader JM, Valdés S, Rojo Martínez G, et al.: Thyroid hormone receptor alpha gene variants increase the risk of developing obesity and show gene-diet interactions. Int J Obes (Lond) 2013, 37:1499-505.
- [31]Amorim BS, Ueta CB, Freitas BC, Nassif RJ, Gouveia CH, Christoffolete MA, et al.: A TRbeta-selective agonist confers resistance to diet-induced obesity. J Endocrinol 2009, 203:291-9.
- [32]Nannipieri M, Cecchetti F, Anselmino M, Camastra S, Niccolini P, Lamacchia M, et al.: Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes 2009, 33:1001-6.
- [33]Ortega FJ, Jílková ZM, Moreno-Navarrete JM, Pavelka S, Rodriguez-Hermosa JI, Kopeck Ygrave J, et al.: Type I iodothyronine 5'-deiodinase mRNA and activity is increased in adipose tissue of obese subjects. Int J Obes 2012, 36:320-4.
- [34]Barbe P, Larrouy D, Boulanger C, Chevillotte E, Viguerie N, Thalamas C, et al.: Triiodothyronine-mediated up-regulation of UCP2 and UCP3 mRNA expression in human skeletal muscle without coordinated induction of mitochondrial respiratory chain genes. FASEB J 2001, 15:13-5.
- [35]Gjedde S, Gormsen LC, Riis AL, Jørgensen JO, Rungby J, Møller N, et al.: Reduced expression of uncoupling protein 2 in adipose tissue in patients with hypothyroidism. J Clin Endocrinol Metab 2010, 95:3537-41.
- [36]Jia JJ, Zhang X, Ge CR, Jois M: The polymorphisms of UCP2 and UCP3 genes associated with fat metabolism, obesity and diabetes. Obes Rev 2009, 10:519-26.
- [37]Brondani LA, Assmann TS, de Souza BM, Bouças AP, Canani LH, Crispim D: Meta-analysis reveals the association of common variants in the uncoupling protein (UCP) 1-3 genes with body mass index variability. PLoS One 2014, 9:e96411.
- [38]Beranger GE, Karbiener M, Bariquissau V, Pisani DF, Scheideler M, Langin D, et al.: In vitro brown and “brite”/”beige” adipogenesis: human cellular models and molecular aspects. Biochim Biophys Acta 1831, 2013:905-14.
- [39]Nedergaard J, Ricquier D, Kozak LP: Uncoupling proteins: current status and therapeutic prospects. EMBO Rep 2005, 6:917-21.
- [40]Elabd C, Chiellini C, Carmona M, Galitzky J, Cochet O, Petersen R, et al.: Human multipotent adipose-derived stem cells differentiate into functional brown adipocytes. Stem Cells 2009, 27:2753-60.
- [41]Matsuzawa Y, Funahashi T, Nakamura T: The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb 2011, 18:629-39.
- [42]Lim U, Song MA: Dietary and lifestyle factors of DNA methylation. Methods Mol Biol 2012, 863:359-76.
- [43]Herrera BM, Keildson S, Lindgren CM: Genetics and epigenetics of obesity. Maturitas 2011, 69:41-9.
- [44]Yan L, Zhou J, Gao Y, Ghazal S, Lu L, Bellone S, et al. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. Oncogene. 2014. doi:10.1038/onc.2014.236. [Epub ahead of print]
- [45]Kodach LL, Jacobs RJ, Voorneveld PW, Wildenberg ME, Verspaget HW, van Wezel T, et al.: Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway. Gut 2011, 60:1544-53.